Hub : Traits :

Smoking status: Current

33 significantly associated models · 22 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 43476957 45088053 1 1 1.5e-07 5.8e-11 2.7e-05 59 ST3GAL3
2 9 126927285 129422783 8 2 8.5e-10 4.5e-08 7.8e-01 100 MAPKAP1 PRPS1P2
3 9 135521303 136922700 1 1 1.6e-07 2.4e-19 1.5e-15 21 SURF1
4 10 103550604 105694301 7 2 5.2e-09 3.6e-08 6.0e-02 88 ACTR1A NT5C2
5 11 16709350 18106069 1 1 2.2e-07 3.8e-07 4.9e-02 85 KCNJ11
6 15 46780520 48764942 1 1 8.9e-08 1.4e-08 3.4e-03 73 SEMA6D
7 20 61636050 62912463 1 1 4.1e-07 6.1e-07 1.0e+00 100 ARFRP1
8 22 41181586 43674249 2 2 1.3e-07 1.9e-07 1.0e+00 100 ACO2 RRP7B

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Crohns Disease (2017) 3.79 3 1 3.0 0.00 1.0e+00 ACO2 ARFRP1 NT5C2
Irritable Bowel Disease (IBD) 4.09 2 1 3.0 0.00 1.0e+00 ARFRP1 KCNJ11
Ulcerative Colitis (UC) 2.79 2 1 3.0 0.00 1.0e+00 ARFRP1 KCNJ11
Verbal and Numeric Reasoning (VNR) 1.79 2 0 0.0 0.00 1.0e+00 ACTR1A ST3GAL3
Prostate Cancer 3.48 1 1 3.0 0.00 1.0e+00 ARFRP1
Crohns Disease (2012) 3.66 2 1 3.0 0.00 1.0e+00 ACO2 ARFRP1
Schizophrenia 3.40 3 1 3.0 0.00 1.0e+00 ACTR1A KCNJ11 ST3GAL3
Ulcerative Colitis 2.80 2 1 3.0 0.00 1.0e+00 ARFRP1 KCNJ11
Blood Eosinophil Count 0.96 4 0 0.0 0.38 6.2e-01 ACO2 ARFRP1 KCNJ11 SURF1
Blood Platelet Count 1.47 6 3 9.1 -0.62 1.9e-01 ACO2 ARFRP1 KCNJ11 NT5C2 RRP7B ST3GAL3
Blood Red Count 1.06 4 3 9.1 0.62 3.8e-01 ARFRP1 MAPKAP1 ST3GAL3 SURF1
Blood White Count 1.84 5 3 9.1 -0.98 2.9e-03 ACTR1A ARFRP1 NT5C2 SEMA6D SURF1
Heel T-Score 0.81 3 0 0.0 0.00 1.0e+00 ACTR1A ARFRP1 NT5C2
BMI 1.34 4 0 0.0 -1.00 9.6e-04 ACTR1A ARFRP1 MAPKAP1 RRP7B
Height 1.69 10 4 12.1 0.38 2.8e-01 ACO2 ACTR1A ARFRP1 KCNJ11 MAPKAP1 NT5C2 PRPS1P2 RRP7B ST3GAL3 SURF1
Waist Hip Ratio (WHR) 1.86 3 0 0.0 0.00 1.0e+00 MAPKAP1 PRPS1P2 SEMA6D
Systolic Blood Pressure 2.93 4 2 6.1 0.95 5.3e-02 ACTR1A KCNJ11 MAPKAP1 ST3GAL3
Smoking Status 18.80 11 9 27.3 -0.98 2.9e-07 ACO2 ACTR1A ARFRP1 KCNJ11 MAPKAP1 NT5C2 PRPS1P2 RRP7B SEMA6D ST3GAL3 SURF1
Allergy or Eczema 2.89 3 1 3.0 0.00 1.0e+00 ACO2 ARFRP1 NT5C2
Cardiovascular Disease 1.79 2 0 0.0 0.00 1.0e+00 KCNJ11 MAPKAP1
Hypothyroidism (self reported) 0.95 1 0 0.0 0.00 1.0e+00 KCNJ11
Respiratory disease 2.65 2 0 0.0 0.00 1.0e+00 ACO2 ARFRP1
Type 2 Diabetes (T2D) 2.34 2 0 0.0 0.00 1.0e+00 ARFRP1 KCNJ11
Lung FEV1/FVC ratio 0.99 2 1 3.0 0.00 1.0e+00 ACTR1A NT5C2
Lung FVC 3.46 2 1 3.0 0.00 1.0e+00 ARFRP1 PRPS1P2
Neuroticism 1.86 2 0 0.0 0.00 1.0e+00 ACTR1A PRPS1P2
Chronotype (morning person) 1.84 2 0 0.0 0.00 1.0e+00 ACO2 ST3GAL3
Hair Pigment 0.09 1 0 0.0 0.00 1.0e+00 ARFRP1
Tanning 0.31 1 0 0.0 0.00 1.0e+00 MAPKAP1
Hand grip strength (left) 4.12 4 1 3.0 0.09 9.1e-01 ACTR1A MAPKAP1 NT5C2 PRPS1P2
Sensitivity / hurt feelings 2.24 2 0 0.0 0.00 1.0e+00 MAPKAP1 PRPS1P2
Relative age of first facial hair 1.34 1 0 0.0 0.00 1.0e+00 RRP7B
Systolic blood pressure, automated reading 2.24 2 0 0.0 0.00 1.0e+00 KCNJ11 MAPKAP1
Medication for hormone replacement therapy 1.58 1 0 0.0 0.00 1.0e+00 ST3GAL3
Vitamin and mineral supplements 2.98 2 0 0.0 0.00 1.0e+00 ACTR1A NT5C2
Pack years adult smoking proportion 5.83 4 0 0.0 0.99 5.6e-03 MAPKAP1 PRPS1P2 SEMA6D SURF1
Impedance of leg (right) 1.84 4 1 3.0 0.33 6.7e-01 ACTR1A KCNJ11 PRPS1P2 SEMA6D
Leg fat-free mass (left) 1.75 4 1 3.0 -0.32 6.8e-01 ACO2 ACTR1A PRPS1P2 SEMA6D
Trunk fat percentage 1.94 3 1 3.0 0.00 1.0e+00 ARFRP1 MAPKAP1 SEMA6D
Hand grip strength (right) 4.17 4 2 6.1 0.03 9.7e-01 ACTR1A MAPKAP1 NT5C2 PRPS1P2
Townsend deprivation index at recruitment 4.02 4 0 0.0 1.00 1.1e-03 ACTR1A MAPKAP1 PRPS1P2 ST3GAL3
Current tobacco smoking 17.84 11 9 27.3 1.00 4.0e-12 ACO2 ACTR1A ARFRP1 KCNJ11 MAPKAP1 NT5C2 PRPS1P2 RRP7B SEMA6D ST3GAL3 SURF1
Maternal smoking around birth 7.23 4 1 3.0 1.00 4.2e-03 ACTR1A NT5C2 ST3GAL3 SURF1
Frequency of unenthusiasm / disinterest in last 2 weeks 2.64 1 0 0.0 0.00 1.0e+00 ST3GAL3
Relative age voice broke 1.99 1 0 0.0 0.00 1.0e+00 RRP7B
Age when periods started (menarche) 3.28 2 1 3.0 0.00 1.0e+00 PRPS1P2 ST3GAL3
High blood pressure 1.66 2 0 0.0 0.00 1.0e+00 KCNJ11 MAPKAP1
Hayfever, allergic rhinitis or eczema 2.65 3 0 0.0 0.00 1.0e+00 ACO2 ARFRP1 NT5C2
Sitting height 1.66 7 0 0.0 -0.75 5.0e-02 ACO2 KCNJ11 MAPKAP1 PRPS1P2 RRP7B ST3GAL3 SURF1
Chronic bronchitis/emphysema (father) 1.72 1 0 0.0 0.00 1.0e+00 ARFRP1
Body mass index (BMI) 1.63 3 0 0.0 0.00 1.0e+00 ACTR1A ARFRP1 SEMA6D
Impedance of leg (left) 1.99 5 1 3.0 0.35 5.6e-01 ACTR1A ARFRP1 KCNJ11 PRPS1P2 SEMA6D
Leg predicted mass (left) 1.75 5 1 3.0 -0.03 9.6e-01 ACO2 ACTR1A NT5C2 PRPS1P2 SEMA6D
Trunk fat mass 1.86 3 1 3.0 0.00 1.0e+00 ACO2 ARFRP1 SEMA6D
Waist circumference 1.76 4 1 3.0 0.97 3.3e-02 ACTR1A ARFRP1 MAPKAP1 NT5C2
Number of incorrect matches in round 1.67 1 0 0.0 0.00 1.0e+00 NT5C2
Past tobacco smoking 8.38 6 3 9.1 -0.96 2.5e-03 ACTR1A KCNJ11 MAPKAP1 NT5C2 PRPS1P2 ST3GAL3
Alcohol usually taken with meals 4.30 3 0 0.0 0.00 1.0e+00 ACTR1A NT5C2 SEMA6D
Nervous feelings 3.23 2 1 3.0 0.00 1.0e+00 ACTR1A PRPS1P2
Forced vital capacity (FVC) 2.98 3 2 6.1 0.00 1.0e+00 ARFRP1 NT5C2 PRPS1P2
Qualifications: None of the above 4.81 3 1 3.0 0.00 1.0e+00 ACTR1A SEMA6D ST3GAL3
Mouth/teeth dental problems 3.18 1 0 0.0 0.00 1.0e+00 PRPS1P2
Allergy 3.09 2 2 6.1 0.00 1.0e+00 ACO2 ARFRP1
Pain all over the body in last month 2.82 1 0 0.0 0.00 1.0e+00 ARFRP1
Diabetes (self-reported) 1.87 1 0 0.0 0.00 1.0e+00 KCNJ11
Fluid intelligence score 2.65 2 1 3.0 0.00 1.0e+00 KCNJ11 ST3GAL3
Neuroticism score 1.39 1 0 0.0 0.00 1.0e+00 PRPS1P2
Weight 1.62 4 1 3.0 0.70 3.0e-01 ACO2 ACTR1A ARFRP1 NT5C2
Impedance of arm (right) 1.83 4 1 3.0 -0.54 4.6e-01 ACTR1A KCNJ11 NT5C2 PRPS1P2
Arm fat percentage (right) 1.84 4 0 0.0 -0.81 1.9e-01 ARFRP1 MAPKAP1 RRP7B SEMA6D
Trunk fat-free mass 2.06 5 2 6.1 -0.04 9.5e-01 ACO2 ACTR1A MAPKAP1 NT5C2 PRPS1P2
Hip circumference 1.76 3 1 3.0 0.00 1.0e+00 ACTR1A ARFRP1 SEMA6D
Alcohol intake versus 10 years previously 2.23 1 0 0.0 0.00 1.0e+00 NT5C2
Worrier / anxious feelings 4.05 3 1 3.0 0.00 1.0e+00 ACTR1A NT5C2 ST3GAL3
Frequency of tiredness / lethargy in last 2 weeks 2.12 1 0 0.0 0.00 1.0e+00 PRPS1P2
Forced expiratory volume in 1-second (FEV1) 3.31 3 2 6.1 0.00 1.0e+00 ACTR1A ARFRP1 PRPS1P2
Pulse rate 2.53 2 0 0.0 0.00 1.0e+00 MAPKAP1 PRPS1P2
Happiness 1.95 1 0 0.0 0.00 1.0e+00 ACO2
Qualifications: A levels/AS levels or equivalent 4.64 3 1 3.0 0.00 1.0e+00 ACTR1A SEMA6D ST3GAL3
Mouth/teeth dental problems: Dentures 3.93 2 0 0.0 0.00 1.0e+00 ACTR1A KCNJ11
Asthma 1.85 2 0 0.0 0.00 1.0e+00 ACO2 ARFRP1
Lung cancer (father) 2.94 1 0 0.0 0.00 1.0e+00 RRP7B
Forced expiratory volume in 1-second (FEV1), Best measure 2.62 2 1 3.0 0.00 1.0e+00 ARFRP1 PRPS1P2
Impedance of arm (left) 1.91 2 1 3.0 0.00 1.0e+00 ACTR1A KCNJ11
Arm fat mass (right) 1.71 3 0 0.0 0.00 1.0e+00 ACTR1A ARFRP1 SEMA6D
Trunk predicted mass 2.08 5 2 6.1 -0.05 9.4e-01 ACO2 ACTR1A MAPKAP1 NT5C2 PRPS1P2
Standing height 1.63 5 3 9.1 -0.97 6.5e-03 ACO2 KCNJ11 MAPKAP1 PRPS1P2 RRP7B
Seen doctor (GP) for nerves, anxiety, tension or depression 2.07 1 0 0.0 0.00 1.0e+00 PRPS1P2
Birth weight of first child 1.92 1 0 0.0 0.00 1.0e+00 SEMA6D
Peak expiratory flow (PEF) 3.13 3 1 3.0 0.00 1.0e+00 ACTR1A NT5C2 PRPS1P2
Pulse wave reflection index 2.90 1 0 0.0 0.00 1.0e+00 MAPKAP1
Qualifications: O levels/GCSEs or equivalent 2.70 2 0 0.0 0.00 1.0e+00 KCNJ11 ST3GAL3
Medication for cholesterol, blood pressure or diabetes 1.11 1 0 0.0 0.00 1.0e+00 MAPKAP1
Medication: Amlodipine 1.52 1 0 0.0 0.00 1.0e+00 MAPKAP1
Forced vital capacity (FVC), Best measure 2.28 2 1 3.0 0.00 1.0e+00 ARFRP1 PRPS1P2
Body fat percentage 2.05 3 1 3.0 0.00 1.0e+00 ARFRP1 MAPKAP1 SEMA6D
Leg fat percentage (right) 2.13 2 1 3.0 0.00 1.0e+00 ARFRP1 MAPKAP1
Arm fat-free mass (right) 2.00 4 1 3.0 0.17 8.3e-01 ACO2 ACTR1A NT5C2 PRPS1P2
Exposure to tobacco smoke outside home 4.19 1 0 0.0 0.00 1.0e+00 ACTR1A
Comparative body size at age 10 1.55 1 0 0.0 0.00 1.0e+00 ACO2
Worry too long after embarrassment 2.26 1 0 0.0 0.00 1.0e+00 PRPS1P2
Seen a psychiatrist for nerves, anxiety, tension or depression 2.08 1 0 0.0 0.00 1.0e+00 PRPS1P2
Wheeze or whistling in the chest in last year 3.69 1 1 3.0 0.00 1.0e+00 ARFRP1
Qualifications: College or University degree 5.46 7 3 9.1 -0.95 1.0e-03 ACTR1A ARFRP1 NT5C2 PRPS1P2 RRP7B SEMA6D ST3GAL3
Medication for pain relief, constipation, heartburn 1.39 1 0 0.0 0.00 1.0e+00 PRPS1P2
Medication: Blood pressure 1.12 1 0 0.0 0.00 1.0e+00 MAPKAP1
Migraine (self-reported) 1.98 1 0 0.0 0.00 1.0e+00 RRP7B
Whole body fat mass 1.96 3 1 3.0 0.00 1.0e+00 ACTR1A ARFRP1 SEMA6D
Leg fat mass (right) 2.05 2 1 3.0 0.00 1.0e+00 ACTR1A ARFRP1
Arm predicted mass (right) 2.01 3 1 3.0 0.00 1.0e+00 ACTR1A NT5C2 PRPS1P2
Pulse rate, automated reading 4.25 2 1 3.0 0.00 1.0e+00 ARFRP1 MAPKAP1
Alcohol intake frequency. 1.61 1 0 0.0 0.00 1.0e+00 RRP7B
Comparative height size at age 10 2.01 3 1 3.0 0.00 1.0e+00 KCNJ11 MAPKAP1 ST3GAL3
Suffer from 'nerves' 1.62 2 0 0.0 0.00 1.0e+00 ACTR1A PRPS1P2
Overall health rating 2.84 2 0 0.0 0.00 1.0e+00 MAPKAP1 PRPS1P2
Family relationship satisfaction 2.21 1 0 0.0 0.00 1.0e+00 ACO2
Qualifications: NVQ or HND or HNC or equivalent 2.61 1 0 0.0 0.00 1.0e+00 ACTR1A
Knee pain experienced in last month 2.09 2 0 0.0 0.00 1.0e+00 ACTR1A NT5C2
Hypertension (Self-reported) 1.66 2 0 0.0 0.00 1.0e+00 KCNJ11 MAPKAP1
Illnesses of father: Heart disease 1.64 1 0 0.0 0.00 1.0e+00 ST3GAL3
Smoking status: Previous 4.07 2 0 0.0 0.00 1.0e+00 ACTR1A NT5C2
Forced expiratory volume in 1-second (FEV1), predicted 1.37 1 0 0.0 0.00 1.0e+00 ACO2
Whole body fat-free mass 1.93 4 2 6.1 0.08 9.2e-01 ACO2 ACTR1A NT5C2 PRPS1P2
Leg fat-free mass (right) 1.66 4 1 3.0 -0.36 6.4e-01 ACO2 ACTR1A PRPS1P2 SEMA6D
Arm fat percentage (left) 1.90 4 0 0.0 -0.80 2.0e-01 ARFRP1 MAPKAP1 RRP7B SEMA6D
Handedness (chirality/laterality): Left-handed 1.54 1 0 0.0 0.00 1.0e+00 SEMA6D
Long-standing illness, disability or infirmity 2.28 2 0 0.0 0.00 1.0e+00 ARFRP1 PRPS1P2
Ever had bowel cancer screening 2.49 1 0 0.0 0.00 1.0e+00 SURF1
Diabetes diagnosed by doctor 1.99 1 0 0.0 0.00 1.0e+00 KCNJ11
Qualifications: nursing, teaching 2.49 2 0 0.0 0.00 1.0e+00 ACTR1A ST3GAL3
Medication: Laxatives (e.g. Dulcolax, Senokot) 2.17 1 0 0.0 0.00 1.0e+00 MAPKAP1
Back pain experienced in last month 2.43 1 0 0.0 0.00 1.0e+00 KCNJ11
Mineral and other dietary supplements 2.10 2 0 0.0 0.00 1.0e+00 ACTR1A NT5C2
Asthma (self-reported) 1.88 2 0 0.0 0.00 1.0e+00 ACO2 ARFRP1
Osteoarthritis (self-reported) 2.86 1 0 0.0 0.00 1.0e+00 MAPKAP1
Medication: Gliclazide 1.67 1 0 0.0 0.00 1.0e+00 KCNJ11
Forced expiratory volume in 1-second (FEV1), predicted percentage 3.14 2 1 3.0 0.00 1.0e+00 ARFRP1 PRPS1P2
Whole body water mass 1.93 4 2 6.1 0.08 9.2e-01 ACO2 ACTR1A NT5C2 PRPS1P2
Leg predicted mass (right) 1.66 4 1 3.0 -0.36 6.4e-01 ACO2 ACTR1A PRPS1P2 SEMA6D
Arm fat mass (left) 1.79 3 0 0.0 0.00 1.0e+00 ACTR1A ARFRP1 SEMA6D
Number of self-reported non-cancer illnesses 2.63 2 0 0.0 0.00 1.0e+00 ACO2 ARFRP1
Mother's age at death 2.74 1 0 0.0 0.00 1.0e+00 MAPKAP1
Financial situation satisfaction 3.21 1 0 0.0 0.00 1.0e+00 KCNJ11
Medication: Blood pressure 1.42 1 0 0.0 0.00 1.0e+00 KCNJ11
High cholesterol (Self-reported) 1.14 1 0 0.0 0.00 1.0e+00 SURF1
Ever smoked 7.59 4 3 9.1 0.99 6.3e-03 ACTR1A KCNJ11 NT5C2 PRPS1P2
Basal metabolic rate 1.81 4 1 3.0 0.08 9.2e-01 ACO2 ACTR1A NT5C2 PRPS1P2
Leg fat percentage (left) 2.31 2 1 3.0 0.00 1.0e+00 ARFRP1 MAPKAP1
Arm fat-free mass (left) 1.97 4 1 3.0 0.51 4.9e-01 ACTR1A ARFRP1 NT5C2 PRPS1P2
Risk taking 2.23 1 0 0.0 0.00 1.0e+00 NT5C2
Diastolic blood pressure, automated reading 2.50 4 0 0.0 0.32 6.8e-01 ARFRP1 MAPKAP1 NT5C2 ST3GAL3
Myopia 3.61 1 0 0.0 0.00 1.0e+00 PRPS1P2
Vascular/heart problems diagnosed by doctor 1.48 2 0 0.0 0.00 1.0e+00 MAPKAP1 NT5C2
Cholesterol lowering medication 1.52 1 0 0.0 0.00 1.0e+00 SURF1
Medication: Omeprazole (e.g. Zanprol) 3.06 2 0 0.0 0.00 1.0e+00 ARFRP1 KCNJ11
Pain experienced in last month 2.29 2 0 0.0 0.00 1.0e+00 ARFRP1 PRPS1P2
Pack years of smoking 5.33 2 0 0.0 0.00 1.0e+00 SEMA6D SURF1
Impedance of whole body 2.05 3 1 3.0 0.00 1.0e+00 ACTR1A KCNJ11 PRPS1P2
Leg fat mass (left) 2.06 3 1 3.0 0.00 1.0e+00 ACTR1A ARFRP1 NT5C2
Arm predicted mass (left) 1.94 5 1 3.0 0.25 6.9e-01 ACO2 ACTR1A ARFRP1 NT5C2 PRPS1P2

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 1 0.0286 1.68
GTEx Adipose Visceral Omentum 1 0.0491 1.65
GTEx Adrenal Gland 0 0.0000 1.65
GTEx Artery Aorta 0 0.0000 1.60
GTEx Artery Coronary 1 0.0845 1.59
GTEx Artery Tibial 2 0.0532 1.60
GTEx Brain Caudate basal ganglia 0 0.0000 1.60
GTEx Brain Cerebellar Hemisphere 1 0.0672 1.65
GTEx Brain Cerebellum 2 0.1009 1.60
GTEx Brain Cortex 2 0.1932 1.70
GTEx Brain Frontal Cortex BA9 0 0.0000 1.66
GTEx Brain Hippocampus 0 0.0000 1.49
GTEx Brain Hypothalamus 0 0.0000 1.61
GTEx Brain Nucleus accumbens basal ganglia 0 0.0000 1.59
GTEx Brain Putamen basal ganglia 0 0.0000 1.45
GTEx Breast Mammary Tissue 0 0.0000 1.66
GTEx Breast Mammary Tissue (Male) 0 0.0000 1.59
GTEx Breast Mammary Tissue (Female) 0 0.0000 1.51
GTEx Cells EBV-transformed lymphocytes 0 0.0000 1.59
GTEx Cells Transformed fibroblasts 2 0.0476 1.63
GTEx Colon Sigmoid 0 0.0000 1.70
GTEx Colon Transverse 0 0.0000 1.57
GTEx Esophagus Gastroesophageal Junction 0 0.0000 1.66
GTEx Esophagus Mucosa 0 0.0000 1.59
GTEx Esophagus Muscularis 0 0.0000 1.66
GTEx Heart Atrial Appendage 0 0.0000 1.63
GTEx Heart Left Ventricle 0 0.0000 1.68
GTEx Liver 1 0.1395 1.55
GTEx Lung 0 0.0000 1.56
GTEx Muscle Skeletal 2 0.0692 1.69
GTEx Nerve Tibial 1 0.0231 1.60
GTEx Ovary 0 0.0000 1.54
GTEx Pancreas 0 0.0000 1.70
GTEx Pituitary 0 0.0000 1.60
GTEx Prostate 0 0.0000 1.67
GTEx Skin Not Sun Exposed Suprapubic 1 0.0407 1.61
GTEx Skin Sun Exposed Lower leg 2 0.0549 1.57
GTEx Small Intestine Terminal Ileum 0 0.0000 1.64
GTEx Spleen 1 0.0709 1.61
GTEx Stomach 0 0.0000 1.71
GTEx Testis 0 0.0000 1.61
GTEx Thyroid 1 0.0250 1.61
GTEx Uterus 0 0.0000 1.63
GTEx Vagina 0 0.0000 1.50
GTEx Whole Blood 1 0.0502 1.60
METSIM Adipose 1 0.0217 1.55
NTR Blood 2 0.0833 1.54
ROSMAP Brain Pre-frontal Cortex 2 0.0455 1.59
YFS Blood 0 0.0000 1.51
CommonMind Brain Pre-frontal Cortex 2 0.0372 1.56
TCGA Breast Tumor 2 0.2608 1.59
TCGA Breast Normal 0 0.0000 1.46
TCGA Ovarian Tumor 1 0.0342 1.53
TCGA Prostate Tumor 1 0.0289 1.58